Discontinuation typically leads to weight regain unless lifestyle factors have substantially shifted in the meantime, which is why we work on those alongside the medication, not after
In addition to glycemic control, the market is increasingly being shaped by demand for obesity management and cardiometabolic risk reduction
Just get the proper guidance so youre clear on whats proven versus what's still a guess
Quick Answer: GLP-1 receptor agonists may reduce sugar cravings through effects on brain reward centres, though definitive evidence is limited and individual responses vary considerably
Jensterle M, Salamun V, Kocjan T, Vrtacnik Bokal E, Janez A
Effects of liraglutide on left ventricular function in patients with non-ST-segment elevation myocardial infarction